Cardio Diagnostics Holdings, Inc.
CDIOHealthcare|Biotechnology|US
$1.65
-0.02 (-1.43%)
DCF Value
$2.24
Tangible Book / Share
$1.93
Cash / Share
$1.33
Financials
Financial Snapshot
Market Cap
$4.9M
Enterprise Value
$1.2M
Revenue (TTM)
$15.2K
Net Income (TTM)
-$6.5M
Cash & Investments
$3.9M
Net Cash
$3.7M
Free Cash Flow (TTM)
-$5.8M
Operating CF (TTM)
-$5.8M
Debt/Equity
0.04
Cash Runway & Burn Rate
Cash on Hand
$3.9M
Quarterly Burn
$1.4M
Monthly Burn
$481.9K
Est. Runway
~2.7 quarters
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $237.1K | $512.8K | $4.1M | $1.3M | $7.8M | $5.1M | $3.9M | |
| Operating Cash Flow | $25.9K | -$585.3K | -$5.1M | -$5.7M | -$5.0M | -$5.7M | -$5.8M | |
| Free Cash Flow | -$4.1K | -$699.3K | -$5.2M | -$6.5M | -$5.4M | -$5.9M | -$5.8M | |
| Capital Expenditure | -$29.9K | -$114.0K | -$76.2K | -$794.3K | -$404.2K | -$187.3K | -$18.8K | |
| Financing Cash Flow | $240.0K | $1.2M | $9.1M | $3.6M | $11.9M | $3.4M | $3.6M |
R&D Spending
R&D (TTM)
$753.8K
R&D Intensity
4964.3%
R&D Growth vs Prior
+17.6%
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $901.00 | $950.00 | $17.1K | $34.9K | $14.8K | $15.2K | |
| R&D Expense | $1.5K | $31.5K | $40.4K | $145.2K | $228.0K | $641.2K | $753.8K | |
| R&D % of Revenue | — | 3492.6% | 4257.7% | 850.8% | 653.4% | 4325.2% | 4964.3% | |
| SG&A | $597.0K | $573.9K | $4.5M | $7.1M | $8.2M | $5.8M | $5.7M |
Income Statement
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $901.00 | $950.00 | $17.1K | $34.9K | $14.8K | $15.2K | |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $94.7K | |
| Gross Profit | $0.00 | $901.00 | $950.00 | $17.1K | $34.9K | $14.8K | -$83.1K | |
| R&D | $1.5K | $31.5K | $40.4K | $145.2K | $228.0K | $641.2K | $753.8K | |
| SG&A | $597.0K | $573.9K | $4.5M | $7.1M | $8.2M | $5.8M | $5.7M | |
| Operating Income | -$609.2K | -$620.4K | -$4.5M | -$7.2M | -$8.4M | -$6.5M | -$6.5M | |
| Interest Expense | $0.00 | $0.00 | $0.00 | $6.7M | $18.6K | $14.8K | $6.9K | |
| Pretax Income | -$605.2K | -$620.4K | -$4.7M | -$8.4M | -$8.4M | -$6.5M | -$6.5M | |
| Net Income | -$605.2K | -$620.4K | -$4.7M | -$8.4M | -$8.4M | -$6.5M | -$6.5M | |
| EPS (Diluted) | -0.06 | -1.96 | -45.30 | -19.80 | -9.30 | -3.71 | -2.53 | |
| EBITDA | -$598.5K | -$604.4K | -$4.6M | -$1.5M | -$8.1M | -$6.1M | -$6.2M | |
| Shares Out. (M) | 9.51 | 0.32 | 3.09 | 0.42 | 26.89 | 1.75 | 2.96 |
Balance Sheet
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $237.1K | $512.8K | $4.1M | $1.3M | $7.8M | $5.1M | $3.9M | |
| Short-Term Investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Current Assets | $245.9K | $803.5K | $5.9M | $2.8M | $8.8M | $5.9M | $4.4M | |
| Total Assets | $446.4K | $1.1M | $6.2M | $4.5M | $10.6M | $7.8M | $6.1M | |
| Total Current Liabilities | $386.0K | $33.9K | $1.9M | $841.1K | $631.7K | $604.8K | $249.6K | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $116.4K | |
| Total Liabilities | $386.0K | $33.9K | $1.9M | $1.5M | $1.1M | $793.1K | $366.0K | |
| Stockholders' Equity | $60.4K | $1.1M | $4.3M | $3.0M | $9.6M | $7.0M | $5.7M | |
| Retained Earnings | -$710.1K | -$1.3M | -$6.0M | -$14.4M | -$22.8M | -$29.3M | -$34.3M |
Cash Flow Statement
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $25.9K | -$585.3K | -$5.1M | -$5.7M | -$5.0M | -$5.7M | -$5.8M | |
| Capital Expenditure | -$29.9K | -$114.0K | -$76.2K | -$794.3K | -$404.2K | -$187.3K | -$18.8K | |
| Free Cash Flow | -$4.1K | -$699.3K | -$5.2M | -$6.5M | -$5.4M | -$5.9M | -$5.8M | |
| Investing Cash Flow | -$29.9K | -$364.0K | -$368.0K | -$794.3K | -$404.2K | -$419.3K | -$249.3K | |
| Financing Cash Flow | $240.0K | $1.2M | $9.1M | $3.6M | $11.9M | $3.4M | $3.6M | |
| Issuance of Stock | $0.00 | $1.1M | $12.0M | $0.00 | $12.5M | $3.8M | $4.0M | |
| Repurchase of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Debt Issuance | $0.00 | $0.00 | $0.00 | $4.5M | $0.00 | -$374.2K | -$269.8K | |
| Stock Based Comp. | $589.3K | $60.0K | $0.00 | $1.3M | $2.6M | $110.2K | $97.5K | |
| Net Change in Cash | $235.9K | $275.7K | $3.6M | -$2.8M | $6.5M | -$2.7M | -$2.4M |
Dilution Tracker
Shares Outstanding
3M
5-Year Share Growth
-81.6%
Stock Issuance (TTM)
$4.0M
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 9.51 | 0.32 | 3.09 | 0.42 | 26.89 | 1.75 | 2.96 | |
| Change vs Prior % | — | -96.7% | 873.6% | -86.3% | 6260.1% | -93.5% | 69.0% | |
| Stock Issuance | $0.00 | $1.1M | $12.0M | $0.00 | $12.5M | $3.8M | $4.0M | |
| Stock Repurchase | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $589.3K | $60.0K | $0.00 | $1.3M | $2.6M | $110.2K | $97.5K |
Margins & Profitability
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Gross Margin % | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -547.0% | |
| Operating Margin % | — | -68862.2% | -478784.3% | -42440.4% | -23977.9% | -43737.5% | -42649.8% | |
| Net Margin % | — | -68862.2% | -490630.0% | -49087.8% | -24028.2% | -43832.5% | -42721.9% | |
| EBITDA Margin % | — | -67086.3% | -488945.8% | -8966.9% | -23182.8% | -41047.1% | -40775.8% | |
| FCF Margin % | — | -77616.0% | -543907.6% | -37893.1% | -15469.5% | -39893.1% | -38202.9% | |
| ROE % | -1002.5% | -58.1% | -108.4% | -283.2% | -87.7% | -93.2% | -89.4% | |
| ROA % | -135.6% | -56.3% | -74.6% | -187.7% | -79.0% | -83.7% | -106.6% | |
| ROIC % | -1009.1% | -58.1% | -88.3% | -171.7% | -79.5% | -84.5% | -108.7% | |
| R&D / Revenue % | — | 3492.6% | 4257.7% | 850.8% | 653.4% | 4325.2% | 4964.3% |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.0% | 0.0% | 5.4% | 1696.3% | 104.5% | -57.5% | |
| Gross Profit | 0.0% | 0.0% | 5.4% | 1696.3% | 104.5% | -57.5% | |
| Operating Income | 0.0% | -1.9% | -633.1% | -59.2% | -15.5% | 22.5% | |
| Net Income | 0.0% | -2.5% | -651.2% | -79.7% | -0.1% | 22.5% | |
| EPS (Diluted) | 0.0% | -2981.8% | -2211.2% | 56.3% | 53.0% | 60.1% | |
| Operating Cash Flow | 0.0% | -2363.4% | -769.8% | -11.4% | 12.0% | -14.7% | |
| Free Cash Flow | 0.0% | -17162.9% | -638.9% | -25.1% | 16.5% | -9.6% | |
| R&D Expense | 0.0% | 1997.9% | 28.5% | 258.9% | 57.0% | 181.3% | |
| SG&A Expense | 0.0% | -3.9% | 682.9% | 57.9% | 14.9% | -29.0% | |
| Total Assets | 0.0% | 146.9% | 467.1% | -28.6% | 137.9% | -26.8% | |
| Book Value / Share | 0.0% | 52984.0% | -58.6% | 402.2% | -94.9% | 1020.3% | |
| Debt | 0.0% | 0.0% | 0.0% | 48.5% | -23.1% | -28.3% | |
| Diluted Shares | 0.0% | -96.7% | 873.6% | -86.3% | 6260.1% | -93.5% |
Valuation
P/E (TTM)At Loss
P/S321.77
10Y Low / Med / High320.16 / 21204.54 / 103701.16
P/B0.85
10Y Low / Med / High0.68 / 77.41 / 46436.16
EV/EBITDAAt Loss
EV/Revenue77.85
10Y Low / Med / High22.35 / 21007.99 / 103132.05
P/FCFAt Loss
Intrinsic Value Models (per share)
DCF Value
$2.24
Tangible Book / Share
$1.93
Net Current Assets / Share
$1.35
Graham Net-Net
$1.21
Cash / Share
$1.33
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| P/E Ratio | -4632.08 | -150.31 | -0.70 | -3.77 | -2.96 | -0.73 | -0.65 | |
| P/S Ratio | 0.00 | 103701.16 | 103366.74 | 1850.92 | 21204.54 | 320.16 | 321.77 | |
| P/B Ratio | 46436.16 | 87.48 | 22.83 | 10.68 | 77.41 | 0.68 | 0.85 | |
| EV/EBITDA | -4683.20 | -153.73 | -20.44 | -20.63 | -90.62 | -0.05 | -0.19 | |
| EV/Revenue | 0.00 | 103132.05 | 99926.22 | 1849.60 | 21007.99 | 22.35 | 77.85 |
Analyst Estimates & Quality
Altman Z-Score
-2.58
Distress
Piotroski F-Score
3
Weak
Forward Estimates (consensus)
| Metric | FY2026 |
|---|---|
| Revenue | $25.0M |
| Net Income | -$28.9M |
| EPS | $-16.50 |
| # Analysts (EPS) | 1 |